Delaware is joining most other states nationwide in a lawsuit against generic drug manufacturers.
42 states and Puerto Rico are suing 20 drug companies and 15 senior executives for conspiring to artificially inflate drug prices.
The complaint alleges the defendants fixed the prices for more than 100 different generic drugs accounting for billions of dollars in the United States market, and affecting the health insurance marketplace as well as taxpayer funded health care programs like Medicare and Medicaid.
The drugs in question treat a wide range of diseases and, in some instances, the coordinated price increases were more 1,000%, the suit claims.
Delaware Attorney General Kathy Jennings said in a statement, “Schemes that tilt the playing field even further against the middle class and our most vulnerable neighbors are unconscionable, unacceptable, and illegal.”
The lawsuit was filed Friday in the U.S. District Court for the District of Connecticut. It seeks damages, civil penalties and actions by the court to restore competition to the generic drug market.